Edition:
United States

People: Johnson & Johnson (JNJ)

JNJ on New York Consolidated

141.24USD
19 Oct 2017
Change (% chg)

$0.56 (+0.40%)
Prev Close
$140.68
Open
$140.71
Day's High
$142.98
Day's Low
$140.54
Volume
3,377,847
Avg. Vol
5,484,180
52-wk High
$142.98
52-wk Low
$109.32

Peterson, Sandra 

Ms. Sandra E. Peterson is Executive Vice President - Group Worldwide Chairman of Johnson & Johnson. Ms. Peterson oversees the Consumer and Consumer Medical Device businesses; the Company's operating infrastructure — Supply Chain, Information Technology, Global Services; Health & Wellness; Global Design; and Health Technology. Prior to joining the Company, Ms. Peterson was Chairman and Chief Executive Officer of Bayer CropScience AG in Germany, previously serving as President and Chief Executive Officer of Bayer Medical Care and President of Bayer HealthCare AG's Diabetes Care Division. Before joining Bayer in 2005, Ms. Peterson held a number of leadership roles at Medco Health Solutions (previously known as Merck-Medco). In April 2016. Ms. Peterson was named Executive Vice President, Group Worldwide Chairman of Johnson & Johnson. Effective June 1, 2017, Ms. Peterson will assume leadership of the Hospital Medical Device business, in addition to her current responsibilities.

Basic Compensation

Total Annual Compensation, USD 2,563,460
Restricted Stock Awards, USD 3,897,070
Long-Term Incentive Plans, USD --
All Other, USD 2,272,250
Fiscal Year Total, USD 8,732,780

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Alex Gorsky

26,871,700

Dominic Caruso

11,304,800

Peter Fasolo

3,621,280

Paulus Stoffels

12,725,500

Michael Ullmann

5,676,350

Joaquin Duato

10,104,500
As Of  31 Dec 2016